Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection

Medical Principles and Practice

Volumn 13, Issue 5, 2004, Pages 273-276

  Buke, A Cagri ^a   Buke, Munir ^a   Altuglu, Imre Erdem ^a   Ciceklioglu, Meltem ^a   Kamcioglu, Saniye ^a   Karakartal, Guney ^a   Huseyinov, Afig ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic hepatitis B; Interleukin 6; Platelet activating factor; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION; SEROLOGY; STATISTICAL SIGNIFICANCE; VIRUS CARRIER; VIRUS INFECTION;

ADULT; CARRIER STATE; CELL CULTURE TECHNIQUES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PLATELET ACTIVATING FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444347176     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079526     Document Type: Article

References (22)

1. Lee MW: Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
2. Andus T, Bauer J, Gerok W: Effects of cytokines on the liver. Hepatology 1991;13:364-375.
3. Foster GR, Thomas HC: Recent advances in the molecular biology of hepatitis B virus: Mutant virus and the host response. Gut 1993;34:1-3.
4. Dudley FJ, Fox RA, Sherlock S: Cellular immunity and hepatitis-associated Australia antigen liver disease. Lancet 1972;1:723-726.
5. Eddleston AL, Williams R: Inadequate antibody response to HbsAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet 1974;2:1543-1545.
6. Wong GH, Goeddel DV: Tumor necrosis factor α and β inhibit virus replication and synergize with interferons. Nature 1986;323:819-822.
7. Torre D, Zeroli C, Giola M, Ferrario G, Fiori GP, Bonetta G, Tambini R: Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 1994;18:194-198.
8. Vingerhoets J, Michielsen P, Vanham G, Bosmans E, Paulij W, Ramon A, Pelckmans P, Kestens L, Leroux-Roels G: HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998;28:8-16.
9. Komatsu Y, Shiratori Y, Hikiba Y, Hashimoto N, Han K, Kawase T, Yoshida H, Okano K, Omata M: Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury. Dig Dis Sci 1996;4:1030-1037.
10. Kasirga E, Coker I, Aydogdu S, Yagci RV, Taneli B, Gousseinov A: Blood levels of leukotrienes (LTC4, D4, E4, B4) and synthesis of leukotriene B4 by peripheral leukocytes in children with acute A and B hepatitis. Turk J Pediatr 1999;4:457-465.
11. Zhou W, McCollum MO, Levine BA, Olson MS: Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology 1992;16:1236-1240.
12. Thomas HC, Pignatelli M, Scully LJ: Viruses and immune reactions in the liver. Scand J Gastroenterol 1985;114:105-117.
13. Camussi G, Tetta C, Baglioni C: The role of platelet activating factor in inflammation. Clin Immunol Immunopathol 1990;57:331-338.
14. Braquet P, Touqui L, Shen TY, Vargaftig BB: Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97-145.
15. Synder F: Chemistry and biochemical aspects of platelet activating factor: A novel class of acetylated ether-linked choline phospholipids. Med Res Rev 1985;5:107-140.
16. Pinckard RN, McManus LN, Hanahan DJ: Chemistry and biology of acetyl glyceryl ether phosphoryl choline (platelet activating factor). Adv Inflamm Res 1982;4:147-150.
17. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M: Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989;10:769-773.
18. Gilles PN, Fey G, Chisari FV: Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol 1992;66:3955-3960.
19. Müller C, Zielinski CC: Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis. Hepatology 1992;15:372-377.
20. Ren H, Zheng DF, Jia XP: Tumor necrosis factor and interleukin 6 in hepatitis C virus infection. Chung Hua Nei Ko Tsa Chih 1992;31:344-346.
21. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ida N: Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jpn 1993;28:18-24.
22. Hodgson PD, Michalac TI: Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 2001;34:1049-1059.